Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Bergmann

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Presse Medicale (Paris, France : 1983)|October 29, 1988
[Abdominal and retroperitoneal masses. Diagnostic value of fine needle cytopunctures. 121 consecutive controlled cases]B Cochand-Priollet, S Chagnon, P Valleur, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2017
Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolismJ Trujillo-Santos, J F Bergmann, C Bortoluzzi, et al.
Medecine Et Maladies Infectieuses|April 16, 2019
Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosisA Lopes, F Mougari, D Chopin, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
HIV Medicine|May 18, 2016
Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patientsP Sellier, A Ostertag, C Collet, et al.
Journal of Viral Hepatitis|October 31, 2013
Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitorJ de Bruijne, X V Thomas, S P Rebers, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
La Revue De Medecine Interne|November 8, 2020
[Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015]J Delforge, S Sovaila, L Alix, et al.
Revue Des Maladies Respiratoires|November 25, 2003
[Clinical practice guideline: medical and nonmedical therapeutic strategies for smoking cessation. Bit of therapeutic practice: management and current practice in smoking cessation]G Lagrue, B Le Foll, P Melihan-Cheinin, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Presse Medicale (Paris, France : 1983)|October 29, 1988
[Abdominal and retroperitoneal masses. Diagnostic value of fine needle cytopunctures. 121 consecutive controlled cases]B Cochand-Priollet, S Chagnon, P Valleur, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2017
Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolismJ Trujillo-Santos, J F Bergmann, C Bortoluzzi, et al.
Medecine Et Maladies Infectieuses|April 16, 2019
Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosisA Lopes, F Mougari, D Chopin, et al.
HIV Medicine|April 6, 2005
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort studyS Fournier, C Chaffaut, A Maillard, et al.
HIV Medicine|May 18, 2016
Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patientsP Sellier, A Ostertag, C Collet, et al.
Journal of Viral Hepatitis|October 31, 2013
Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitorJ de Bruijne, X V Thomas, S P Rebers, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
La Revue De Medecine Interne|November 8, 2020
[Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015]J Delforge, S Sovaila, L Alix, et al.
Revue Des Maladies Respiratoires|November 25, 2003
[Clinical practice guideline: medical and nonmedical therapeutic strategies for smoking cessation. Bit of therapeutic practice: management and current practice in smoking cessation]G Lagrue, B Le Foll, P Melihan-Cheinin, et al.
Pageof 15